<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Romano A</submitter><funding>A.I.L. Sezione di Catania</funding><funding>Università di Catania</funding><funding>Fon.Ca.Ne.Sa</funding><pagination>7237</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9065667</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Since neutrophil extracellular traps formation (NET-osis) can be assessed indirectly by treating healthy neutrophils with blood-derived fluids from patients and then measuring the NETs response, we designed a pilot study to convey high-dimensional cytometry of peripheral blood immune cells and cytokines, combined with clinical features, to understand if NET-osis assessment could be included in the immune risk profiling to early prediction of clinical patterns, disease severity, and viral clearance at 28 days in COVID-19 patients. Immune cells composition of peripheral blood, cytokines concentration and in-vitro NETosis were detected in peripheral blood of 41 consecutive COVID-19 inpatients, including 21 mild breakthrough infections compared to 20 healthy donors, matched for sex and age. Ma</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.</pubmed_title><pmcid>PMC9065667</pmcid><funding_grant_id>Piano per la Ricerca 2018-2020 PIACERI</funding_grant_id><pubmed_authors>Di Raimondo F</pubmed_authors><pubmed_authors>Manuele R</pubmed_authors><pubmed_authors>Botta C</pubmed_authors><pubmed_authors>Montineri A</pubmed_authors><pubmed_authors>Giallongo C</pubmed_authors><pubmed_authors>Volti GL</pubmed_authors><pubmed_authors>Barbato A</pubmed_authors><pubmed_authors>Palumbo GA</pubmed_authors><pubmed_authors>Agodi A</pubmed_authors><pubmed_authors>Romano A</pubmed_authors><pubmed_authors>Puglisi F</pubmed_authors><pubmed_authors>La Ferla L</pubmed_authors><pubmed_authors>Iacobello C</pubmed_authors><pubmed_authors>Triolo AM</pubmed_authors><pubmed_authors>Tibullo D</pubmed_authors><pubmed_authors>Parrinello NL</pubmed_authors><pubmed_authors>Barchitta M</pubmed_authors><pubmed_authors>Siragusa S</pubmed_authors><pubmed_authors>Maugeri A</pubmed_authors></additional><is_claimable>false</is_claimable><name>In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection.</name><description>Since neutrophil extracellular traps formation (NET-osis) can be assessed indirectly by treating healthy neutrophils with blood-derived fluids from patients and then measuring the NETs response, we designed a pilot study to convey high-dimensional cytometry of peripheral blood immune cells and cytokines, combined with clinical features, to understand if NET-osis assessment could be included in the immune risk profiling to early prediction of clinical patterns, disease severity, and viral clearance at 28 days in COVID-19 patients. Immune cells composition of peripheral blood, cytokines concentration and in-vitro NETosis were detected in peripheral blood of 41 consecutive COVID-19 inpatients, including 21 mild breakthrough infections compared to 20 healthy donors, matched for sex and age. Ma</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-06-01T02:57:21.778Z</modification><creation>2024-11-15T17:02:30.314Z</creation></dates><accession>S-EPMC9065667</accession><cross_references><pubmed>35508575</pubmed><doi>10.1038/s41598-022-11157-0</doi></cross_references></HashMap>